Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial.

V, Vaquerizo; MÁ, Plasencia; I, Arribas; R, Seijas; S, Padilla; G, Orive; E, Anitua

doi:10.1016/j.arthro.2013.07.264

Public

Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial.

Shared by NobleBlocks on Oct 1, 2013 • 12:00 AM UTC

Authors:

Vaquerizo V

Plasencia MÁ

Arribas I

Abstract

Purpose The purpose of this study was to compare the efficacy and safety in a randomized, clinical trial of 3 injections of PRGF-Endoret (BTI Biotechnology Institute, Vitoria, Spain) versus one single intra-articular injection of Durolane hyaluronic acid (HA) (Q-MED AB, Uppsala, Sweden) as a treatme...

Discussions